|
1
|
Consensus development conference:
Prophylaxis and treatment of osteoporosis. Am J Med. 90:107–110.
1991. View Article : Google Scholar
|
|
2
|
Burge R, Dawson-Hughes B, Solomon DH, Wong
JB, King A and Tosteson A: Incidence and economic burden of
osteoporosis-related fractures in the United States, 2005-2025. J
Bone Miner Res. 22:465–475. 2007. View Article : Google Scholar
|
|
3
|
Pietschmann P, Rauner M, Sipos W and
Kerschan-Schindl K: Osteoporosis: An age-related and
gender-specific disease-a mini-review. Gerontology. 55:3–12. 2009.
View Article : Google Scholar
|
|
4
|
El Maataoui A, El Maghraoui A, Biaz A,
Elmachtani SI, Dami A, Bouhsain S, Mounach A, Chabraoui L and
Ouzzif Z: Relationships between vertebral fractures, sex hormones
and vitamin D in Moroccan postmenopausal women: A cross sectional
study. BMC Womens Health. 15:412015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karsenty G and Wagner EF: Reaching a
genetic and molecular understanding of skeletal development. Dev
Cell. 2:389–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rodan GA and Martin TJ: Therapeutic
approaches to bone diseases. Science. 289:1508–1514. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Matsumoto Y, Otsuka F, Takano-Narazaki M,
Katsuyama T, Nakamura E, Tsukamoto N, Inagaki K, Sada KE and Makino
H: Estrogen facilitates osteoblast differentiation by upregulating
bone morphogenetic protein-4 signaling. Steroids. 78:513–520. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kelley GA, Kelley KS and Kohrt WM: Effects
of ground and joint reaction force exercise on lumbar spine and
femoral neck bone mineral density in postmenopausal women: A
meta-analysis of randomized controlled trials. BMC Musculoskelet
Disord. 13:1772012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hamrick I, Schrager S and Nye AM:
Treatment of osteoporosis: Current state of the art. Wien Med
Wochenschr. 165:54–64. 2015. View Article : Google Scholar
|
|
10
|
Jackson RD, Wactawski-Wende J, LaCroix AZ,
Pettinger M, Yood RA, Watts NB, Robbins JA, Lewis CE, Beresford SA,
Ko MG, et al: Effects of conjugated equine estrogen on risk of
fractures and BMD in postmenopausal women with hysterectomy:
Results from the women's health initiative randomized trial. J Bone
Miner Res. 21:817–828. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moyer VA; U.S. Preventive Services Task
Force: Vitamin D and calcium supplementation to prevent fractures
in adults: U.S. Preventive Services Task Force recommendation
statement. Ann Intern Med. 158:691–696. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hansen PJ, Knitschke M, Draenert FG, Irle
S and Neff A: Incidence of bisphosphonate-related osteonecrosis of
the jaws (BRONJ) in patients taking bisphosphonates for
osteoporosis treatment-a grossly underestimated risk? Clin Oral
Investig. 17:1829–1837. 2013. View Article : Google Scholar
|
|
13
|
Body JJ, Bergmann P, Boonen S, Devogelaer
JP, Gielen E, Goemaere S, Kaufman JM, Rozenberg S and Reginster JY:
Extraskeletal benefits and risks of calcium, vitamin D and
anti-osteoporosis medications. Osteoporos Int. 23(Suppl 1): S1–S23.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee HA, Castro-Aceituno V, Abbai R, Moon
SS, Kim YJ, Simu SY and Yang DC: Rhizome of Anemarrhena
asphodeloides as mediators of the eco-friendly synthesis of silver
and gold spherical, face-centred cubic nanocrystals and its
anti-migratory and cytotoxic potential in normal and cancer cell
lines. Artif Cells Nanomed Biotechnol. 1–10. 2018.
|
|
15
|
Nian H, Qin LP, Chen WS, Zhang QY, Zheng
HC and Wang Y: Protective effect of steroidal saponins from rhizome
of Anemarrhena asphodeloides on ovariectomy-induced bone loss in
rats. Acta Pharmacol Sin. 27:728–734. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gui Y, Qiu X, Xu Y, Li D and Wang L:
Bu-Shen-Ning-Xin decoction suppresses osteoclastogenesis via
increasing dehydro-epiandrosterone to prevent postmenopausal
osteoporosis. Biosci Trends. 9:169–181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He CC, Hui RR, Tezuka Y, Kadota S and Li
JX: Osteoprotective effect of extract from Achyranthes bidentata in
ovariectomized rats. J Ethnopharmacol. 127:229–234. 2010.
View Article : Google Scholar
|
|
18
|
Lee H, Kim MH, Choi YY, Hong J and Yang
WM: Effects of Cynanchum wilfordii on osteoporosis with inhibition
of bone resorption and induction of bone formation. Mol Med Rep.
17:3758–3762. 2018.
|
|
19
|
Jeon EJ, Lee DH, Kim YJ, Ahn J, Kim MJ,
Hwang JT, Hur J, Kim M, Jang YJ, Ha TY, et al: Effects of yuja peel
extract and its flavanones on osteopenia in ovariectomized rats and
osteoblast differentiation. Mol Nutr Food Res. 60:2587–2601. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Boyce BF, Xiu Y, Li J, Xing L and Yao Z:
NF-κB-mediated regulation of osteoclastogenesis. Endocrinol Metabol
(Seoul). 30:35–44. 2015. View Article : Google Scholar
|
|
22
|
Kanis JA, Melton LJ III, Christiansen C,
Johnston CC and Khaltaev N: The diagnosis of osteoporosis. J Bone
Miner Res. 9:1137–1141. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Johnell O, Kanis JA, Oden A, Johansson H,
De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D,
et al: Predictive value of BMD for hip and other fractures. J Bone
Miner Res. 20:1185–1194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stone KL, Seeley DG, Lui LY, Cauley JA,
Ensrud K, Browner WS, Nevitt MC and Cummings SR;
OsteoporoticFractures Research Group: BMD at multiple sites and
risk of fracture of multiple types: Long-term results from the
Study of Osteoporotic Fractures. J Bone Miner Res. 18:1947–1954.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim MH, Choi YY, Han JM, Lee HS, Hong SB,
Lee SG and Yang WM: Ameliorative effects of Schizandra chinensis on
osteoporosis via activation of estrogen receptor (ER)-α/-β. Food
Funct. 5:1594–1601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sims NA and Gooi JH: Bone remodeling:
Multiple cellular interactions required for coupling of bone
formation and resorption. Semin Cell Dev Biol. 19:444–451. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao JJ, Wronski TJ, Iwaniec U, Phleger L,
Kurimoto P, Boudignon B and Halloran BP: Aging increases
stromal/osteo-blastic cell-induced osteoclastogenesis and alters
the osteoclast precursor pool in the mouse. J Bone Miner Res.
20:1659–1668. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Charles JF and Aliprantis AO: Osteoclasts:
More than ‘bone eaters’. Trends Mol Med. 20:449–459. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boyle WJ, Simonet WS and Lacey DL:
Osteoclast differentiation and activation. Nature. 423:337–342.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yasuda H, Shima N, Nakagawa N, Yamaguchi
K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A,
et al: Osteoclast differentiation factor is a ligand for
osteoprote-gerin/osteoclastogenesis-inhibitory factor and is
identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 95:3597–3602.
1998. View Article : Google Scholar
|
|
31
|
Motiur Rahman M, Takeshita S, Matsuoka K,
Kaneko K, Naoe Y, Sakaue-Sawano A, Miyawaki A and Ikeda K:
Proliferation-coupled osteoclast differentiation by RANKL: Cell
density as a determinant of osteoclast formation. Bone. 81:392–399.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hayman AR: Tartrate-resistant acid
phosphatase (TRAP) and the osteoclast/immune cell dichotomy.
Autoimmunity. 41:218–223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zou W, Hakim I, Tschoep K, Endres S and
Bar-Shavit Z: Tumor necrosis factor-alpha mediates RANK ligand
stimulation of osteoclast differentiation by an autocrine
mechanism. J Cell Biochem. 83:70–83. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yokota K, Sato K, Miyazaki T, Kitaura H,
Kayama H, Miyoshi F, Araki Y, Akiyama Y, Takeda K and Mimura T:
Combination of tumor necrosis factor α and interleukin-6 induces
mouse osteoclast-like cells with bone resorption activity both in
vitro and in vivo. Arthritis Rheumatol. 66:121–129. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Soysa NS and Alles N: NF-kappaB functions
in osteoclasts. Biochem Biophys Res Commun. 378:1–5. 2009.
View Article : Google Scholar
|
|
36
|
Ghosh S and Karin M: Missing pieces in the
NF-kappaB puzzle. Cell. 109(Suppl): S81–S96. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Perkins ND: Integrating cell-signalling
pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol.
8:49–62. 2007. View
Article : Google Scholar
|
|
38
|
Lee ZH and Kim HH: Signal transduction by
receptor activator of nuclear factor kappa B in osteoclasts.
Biochem Biophys Res Commun. 305:211–214. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wagner EF and Eferl R: Fos/AP-1 proteins
in bone and the immune system. Immunol Rev. 208:126–140. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang ZQ, Ovitt C, Grigoriadis AE,
Möhle-Steinlein U, Rüther U and Wagner EF: Bone and haematopoietic
defects in mice lacking c-fos. Nature. 360:741–745. 1992.
View Article : Google Scholar : PubMed/NCBI
|
